Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06906640 · ClinicalTrials.gov registry record · NA
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
A NA study of Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease(CKD), sponsored by Duke University.
- Recruiting
- Registry status
- NA
- Development phase
- 420
- Enrollment target
- 6
- Study locations
NCT06906640 is a NA study of Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease(CKD) that is actively recruiting participants, run by Duke University. The registered enrollment target is 420 participants, below the 505-participant average among 24 other Type 2 Diabetes Mellitus (T2DM) trials with a reported enrollment target (17% lower). The trial reports 6 study locations across 6 states.
The verdict
NCT06906640, a NA study of Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease(CKD), is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- NA
- Development phase
- 420 participants
- Enrollment target
- 6
- Study locations
Study Summary
IRIS-CKD is a two-program implementation study to improve guideline-recommended screening and treatment of chronic kidney disease (CKD) in individuals with type 2 diabetes (T2D) in the United States.
Conditions Studied
Interventions
- OTHER (IRIS-CKD Management Program): Education
- OTHER (IRIS-CKD Management Program): GDMT
Study Locations (6)
Alabama
- University of Alabama - Birmingham
Florida
- Orlando Health - St. Petersburg
Michigan
- University of Michigan - Ann Arbor
Minnesota
- Essentia Institute of Rural Health - Duluth
North Carolina
- Duke University - Durham
Texas
- Baylor Scott & White - Temple
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 420 participants |
| Start Date | 2025-10-28 |
| Est. Completion | 2027-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06906640
The ClinicalTrials.gov registry entry for NCT06906640 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 420 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 505-participant average among 24 other Type 2 Diabetes Mellitus (T2DM) trials with a reported enrollment target (17% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Type 2 Diabetes Mellitus (T2DM) appearing as the primary indexed condition, and to 2 interventions - of which (IRIS-CKD Management Program): Education is the first listed.
NCT06906640 reports 6 study locations spanning 6 distinct geographic areas - top geographies include Alabama, Florida, Michigan.
Frequently Asked Questions
What is clinical trial NCT06906640 about?
NCT06906640 is a clinical study titled "Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)". IRIS-CKD is a two-program implementation study to improve guideline-recommended screening and treatment of chronic kidney disease (CKD) in individuals with type 2 diabetes (T2D) in the United States.
What is the current status of trial NCT06906640?
This trial is currently recruiting. It is a NA study. The enrollment target is 420 participants. The study started on 2025-10-28. Estimated completion is 2027-04-01.
What conditions does trial NCT06906640 study?
This clinical trial studies the following conditions: Type 2 Diabetes Mellitus (T2DM), Chronic Kidney Disease(CKD), Type 2 DM.
What interventions are being tested in trial NCT06906640?
The interventions under investigation include: (IRIS-CKD Management Program): Education (OTHER), (IRIS-CKD Management Program): GDMT (OTHER).
Who is sponsoring clinical trial NCT06906640?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06906640 being conducted?
This trial has 6 study locations across Alabama, Florida, Michigan, Minnesota, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes Mellitus (T2DM)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Achieving Routine Intervention and Screening for Emotional Health
RECRUITING · NA
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
-
Diabetes Electronic Prompt for Improved Care Coordination and Treatment in the ED
RECRUITING · NA
-
Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge
RECRUITING · NA
-
Diabetes Management Using Continuous Glucose Monitors and Remote Patient Monitoring in Underserved Populations
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.